Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

XRP Treasury Evernorth Files SEC Form S-4 for Nasdaq Listing

S&P 500 falls to a key technical spot. Traders watch whether it will hold

It's called 'private credit' — and it could lead to big trouble on Wall Street

Wall St falls as oil surge stokes inflation fears; Russell 2000 slips

U.S. stocks have reached a critical line in the sand. Why the next move could be a 10% drop.